Phase II study of docetaxel in the treatment of patients with advanced non-small cell lung cancer in routine daily practice.
Mattson K, Bosquee L, Dabouis G, Le Groumellec A, Pujol JL, Marien S, Stupp R, Douillard JY, Brägas B, Berille J, Olivares R, Le Chevalier T.
Mattson K, et al. Among authors: le chevalier t, le groumellec a.
Lung Cancer. 2000 Sep;29(3):205-16. doi: 10.1016/s0169-5002(00)00122-7.
Lung Cancer. 2000.
PMID: 10996423
Clinical Trial.